Biovica International (Sweden) Today
| BIOVIC-B | SEK 1.83 0.07 3.68% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Biovica International is trading at 1.83 as of the 23rd of January 2025, a 3.68% down since the beginning of the trading day. The stock's open price was 1.9. Biovica International has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of October 2023 and ending today, the 23rd of January 2025. Click here to learn more.
Biovica International AB , a biotech company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. Biovica International AB was founded in 2009 and is based in Uppsala, Sweden. The company has 39.47 M outstanding shares. More on Biovica International AB
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biovica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biovica International's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biovica International or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Biovica International AB (BIOVIC-B) is traded on Stockholm Exchange in Sweden and employs 27 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 403.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biovica International's market, we take the total number of its shares issued and multiply it by Biovica International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biovica International operates under Healthcare sector and is part of Biotechnology industry. The entity has 39.47 M outstanding shares.
Biovica International AB has accumulated about 89.79 M in cash with (52.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Check Biovica International Probability Of Bankruptcy
Ownership AllocationBiovica International holds a total of 39.47 Million outstanding shares. Almost 96.27 percent of Biovica International outstanding shares are held by general public with 3.73 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biovica Ownership Details
Biovica International Risk Profiles
Although Biovica International's alpha and beta are two of the key measurements used to evaluate Biovica International's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.09 | |||
| Standard Deviation | 6.64 | |||
| Variance | 44.02 | |||
| Risk Adjusted Performance | (0.01) |
Biovica Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biovica International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Biovica International Corporate Management
Elected by the shareholders, the Biovica International's board of directors comprises two types of representatives: Biovica International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biovica. The board's role is to monitor Biovica International's management team and ensure that shareholders' interests are well served. Biovica International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biovica International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cecilia Driving | CFO CEO | Profile | |
| Mattias Bergqvist | VP Devel | Profile | |
| Henrik DVM | Sr Devel | Profile | |
| Anders Rylander | CEO Director | Profile | |
| Tomas Andersson | VP Operations | Profile | |
| Otti Gref | RD Director | Profile | |
| Joakim Arwidson | VP QA | Profile |
Other Information on Investing in Biovica Stock
Biovica International financial ratios help investors to determine whether Biovica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovica with respect to the benefits of owning Biovica International security.